Filter
10399
Filtered Results: 10399
Text search:
measures
Featured
Recommendations
895
New Publications
2676
Language
Document type
No document type
5736
Studies & Reports
1810
Guidelines
1236
Manuals
512
Strategic & Response Plan
357
Fact sheets
296
Training Material
172
Situation Updates
111
Infographics
52
Resource Platforms
40
Videos
28
Brochures
24
Online Courses
21
Dashboards/Maps
3
App
1
Countries / Regions
India
473
Global
435
Kenya
287
Sierra Leone
227
Nigeria
217
Ethiopia
213
Liberia
212
South Africa
208
Western and Central Europe
202
Nepal
192
Uganda
188
Myanmar / Burma
170
Rwanda
154
Syria
144
Tanzania
144
Latin America and the Carribbean
142
Bangladesh
138
Africa
136
Zambia
135
Malawi
135
Ghana
127
Congo, Democratic Republic of
118
Ukraine
105
Philippines
97
Namibia
84
South Sudan
76
Zimbabwe
74
Senegal
71
Guinea
69
Haiti
67
South–East Asia Region
67
West and Central Africa
66
Indonesia
65
Eastern Europe
65
Cambodia
64
Brazil
63
Yemen
62
Mozambique
60
Lesotho
60
East and Southern Africa
59
Middle East and North Africa
59
Germany
56
Russia
56
Asia
53
Burkina Faso
47
Venezuela
47
Eastern Europe and Central Asia
44
Cameroon
41
Botswana
39
Afghanistan
37
Mali
36
Pakistan
34
Eswatini/ Swaziland
32
Colombia
32
Sudan
30
Central African Republic
30
Somalia
26
Jordan
26
Lebanon
26
Western Pacific Region
25
Madagascar
23
Benin
21
Vietnam
21
Thailand
20
Côte d’Ivoire / Ivory Coast
19
USA
19
Iraq
19
China
18
Tajikistan
17
Niger
16
Angola
15
Moldova
15
Palestine
14
Laos
14
Peru
12
Chile
12
Albania
12
Chad
11
Sri Lanka
11
Southern Africa
11
Iran
11
Burundi
10
Libya
10
North America
10
Egypt
9
Ecuador
9
Greece
9
Mexico
9
Paraguay
9
Georgia
9
Guinea-Bissau
8
Turkey
8
Papua New Guinea
8
Argentina
8
North Macedonia
7
Bolivia
7
Italy
7
United Kingdom
7
Spain
7
Saudi Arabia
6
Togo
6
Gambia
6
Malaysia
6
Poland
6
Kyrgyzstan
6
Jamaica
6
Portugal
6
El Salvador
5
Romania
5
Kazakhstan
5
Turkmenistan
5
Tunisia
5
Singapore
4
Serbia
4
Hungary
4
Djibouti
4
Armenia
4
Timor Leste/ East Timor
4
Estonia
4
Morocco
3
Croatia
3
Honduras
3
Guatemala
3
Fiji
3
Bhutan
3
Canada
3
Uzbekistan
3
Japan
3
France
3
Mauritius
3
Belarus
3
Bosnia and Herzegovina
3
Mauritania
2
Ireland
2
Dominican Republic
2
Switzerland
2
Other region
2
Mongolia
2
Qatar
2
Gabon
2
Azerbaijan
2
Israel
2
Vanuatu
1
Nicaragua
1
Solomon Islands
1
North Korea
1
Congo-Brazzaville
1
Bulgaria
1
Lithuania
1
Slovakia
1
Australia
1
Denmark
1
Maldives
1
Norway
1
South Korea
1
Algeria
1
Morocco
1
French Guyana
1
Authors & Publishers
Publication Years
Category
Countries
3919
Clinical Guidelines
653
Public Health
540
Women & Child Health
505
Key Resources
481
Capacity Building
192
Pharmacy & Technologies
86
Annual Report MEDBOX
1
Toolboxes
COVID-19
1290
Mental Health
731
HIV
625
TB
430
Disability
414
Planetary Health
409
Ebola
380
Rapid Response
321
Conflict
304
AMR
293
Caregiver
259
Refugee
238
NTDs
222
NCDs
221
Global Health Education
162
Natural Hazards
152
Pharmacy
146
Health Financing Toolbox
106
Zika
80
Cholera
79
Specific Hazards
67
Polio
61
Social Ethics
45
Typhoon
6
Health Financing
3
South Sudan
2
This document provides guidance to host States on the vetting and registration of volunteers and volunteer organisations. It also provides guidance to UN, NGO and other civil society actors on how they can support and complement State efforts through operational activities.
Indian markets caused a stir across the country.1
According to the Centre for Science and the Environment (CSE), a respected New Delhi-based NGO, most honey brands
sold in India contained varying amounts of antibiotics. Their consumption over time could induce resistance to antibiotics,
putting p...
This draft Roadmap for the Global Health for Peace Initiative has been developed in response to decision WHA75(24) of the 75th World Health Assembly (2022), which requested that WHO develop, in full consultation with Member States and Observers, and in full collaboration with other organizations of ...
This document provides guidance to host States on the vetting and registration of volunteers and volunteer organisations.
It also provides guidance to UN, NGO and other civil society actors on how they can support and complement State ef-forts through operational activities.
Trachoma is the leading infectious cause of blindness (2). It is characterized by repeated
conjunctival infection with particular strains of Chlamydia trachomatis. This scars the conjunctivae and,
in some cases, leads to trichiasis with or without entropion. The abrasive action of eyelashes can
d...
This Trachoma Action Planning – a planning guide – is published by the
International Coalition for Trachoma Control at the request of the
World Health Organization Alliance for the Global Elimination of Trachoma
by 2020.
Countries, partners, and donors are committed to
the global elimination of blinding trachoma by 2020.
Achieving this public health milestone requires more
than funding; it requires health personnel with the
right mix of skills, and well supported and managed
health systems. Mass drug administra...
Trachoma causes more vision loss and blindness than any other infection in the world. This disease is caused by Chlamydia trachomatis bacteria. Other variants or strains of these bacteria can cause a sexually transmitted infection (chlamydia) and disease in lymph nodes.
This is photomicrograph ...
In 2011, ICTC developed a Trachoma Action Plan (TAP) planning guide to support national health officials in endemic countries. This resource was developed to complement the 2020 INSight roadmap by helping countries create specific national plans detailing how they will reach elimination targets in t...
The WHO estimates that 19 million children aged 15 years or younger are visually impaired. Of these, 1.4 million are irreversibly blind and need visual rehabilitation interventions for full psychological and personal development. The remainder have visual problems that could be prevented or treated....
Trachoma is an eye infection that for thousands of years caused many people to go blind across all continents. As the result of development and targeted interventions, trachoma is now limited to an estimated 57 countries, often affecting the poorest
populations of the world. Today, more than 2 mill...
This strategy defines the World Health Organization (WHO) vision and framework for supporting Member States to accelerate the development, implementation and monitoring of their National Action Plan for Health Security (NAPHS) from 2022 to 2026. The National Action Plan for Health Security (NAPHS) ...
Trypanosoma cruzi is the etiological agent of Chagas disease (CD), considered one of the most important parasitic infections in Latin America. Between 25 and 90 million humans are at infection risk via at least one of multiple infection mechanisms. Under natural conditions, the principal transmissio...
At the forefront of DNDi’s efforts to develop new treatments is the need to understand the realities and treatment needs of patients and health care staff in the field. The ultimate goal for human African trypanosomiasis (HAT) is a truly simplified
treatment which can be orally administered, impl...
Theodor Bilharz, a German professor of anatomy and chief of surgery at the Kasr El Ani Hospital of Cairo from 1850, first identified an infective organism, Distomum hematobium in 1851, which was renamed Schistosoma haematobium in 1858. It arose from a cestode worm, Hymenoleptis nana, lying in the sm...
Anopheles stephensi, a highly competent vector of Plasmodium falciparum and P. vivax, is considered an efficient vector of urban malaria. Until 2011, the reported distribution of An. stephensi was confined to certain countries of South Asia and parts of the Arabian Peninsula. Since then, the vector ...
Sleeping sickness is controlled by case detection and treatment but this often only reaches less than 75% of the population. Vector control is capable of completely interrupting HAT transmission but is not used because of expense. We conducted a full scale field trial of a refined vector control tec...
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported ...
The objectives of the meeting were:
1. To step up the commitment of national authorities and technical and financial partners toWHO’s elimination objective for g-HAT.
2. To share achievements, challenges and views on the elimination goal among countries and implementing partners.
3. To assess t...
Wiping out Trachoma from Nepal – How Nepal eliminated trachoma as a public health problem
WHO - 2018
